* Synsorb Biotech Inc., of Calgary, Alberta, was awarded U.S. patentNo. 5,484,773 covering the use of its technology for the treatment ofgastroenteric conditions.
* Xoma Corp., of Berkeley, Calif., was issued U.S. patent No.5,484,704 covering a diagnostic assay for measuring levels oflipopolysaccharide binding protein in human blood.
* Zynaxis Inc., of Malvern, Pa., was awarded patents covering theuse of Zyn-Linker molecules to deliver drugs to reduce unwantedcellular adhesions, and covering nasal delivery of vaccines toimmunize against certain types of respiratory viruses.
(c) 1997 American Health Consultants. All rights reserved.